Hybrids & Chimeras
Inheritable Genetic Modification
Medical Gene Transfer
Sequencing & Genomics
Stem Cell Research
Patents & Other IP
A "Post-Human" Future?
Arts & Culture
Biopolitics, Parties & Pundits
Biotech & Pharma
Reproductive Justice, Health & Rights
Emily Galpern in the News
The Egg Trade — Making Sense of the Market for Human Oocytes
by Debora Spar
New England Journal of Medicine
March 30th, 2007
What we need, therefore, is a fresh debate on egg donation and a new set of policies. We need to consider the health risks and ways of identifying and mitigating them.
New Battle Lines Are Drawn Over Egg Donation
by Lee Romney
Los Angeles Times
September 13th, 2006
"A spirited disagreement over payment has split feminists, with some calling compensation to research subjects coercive and others contending that banning it is paternalistic."
Women's risk is issue in Missouri stem cell debate
by Matt Franck
St. Louis Post-Dispatch
August 6th, 2006
"A proposed constitutional amendment protecting stem cell research is likely to rise or fall on whether Missourians view a mass of cells in a Petri dish as a cure for disease or a human embryo worthy of protection."
How to Watch the Biggest Science Story of 2017
CGS Board Member Leads Redress Call for California Survivors of Eugenic Sterilization
We Launched a New Website!
Slippery Slopes and Biological Curve Balls: Updates on 3-person IVF
California needs to do more than apologize to people it sterilized
Written evidence for the Genomics and Genome-Editing Inquiry of the House of Commons Science and Technology Committee
When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Price
California voters were promised cures. But the state stem cell agency has funded just a trickle of clinical trials
CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 •
• (p) 1.510.665.7760 • (F) 1.510.665.8760